Dr.Warbhe S Lifeline Laboratories Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.11 M
- Company Age 23 Year, 9 Months
- Last Filing with ROC 31 Mar 2024
- Satisfied Charges ₹ 1.27 M
About Dr.Warbhe S Lifeline Laboratories
Dr.Warbhe S Lifeline Laboratories Private Limited (DSLLPL) is a Private Limited Indian Non-Government Company incorporated in India on 30 April 2001 and has a history of 23 years and nine months. Its registered office is in Nagpur, Maharashtra, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.11 M.
The company has closed loans amounting to ₹1.27 M, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Viraj Warbhe and Harish Warbhe serve as directors at the Company.
Company Details
- Location
Nagpur, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U85195MH2001PTC131812
- Company No.
131812
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
30 Apr 2001
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Dr.Warbhe S Lifeline Laboratories?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Viraj Warbhe | Additional Director | 09-Nov-2024 | Current |
Harish Warbhe  | Director | 30-Apr-2001 | Current |
Financial Performance of Dr.Warbhe S Lifeline Laboratories.
Dr.Warbhe S Lifeline Laboratories Private Limited, for the financial year ended 2017, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Dr.Warbhe S Lifeline Laboratories?
In 2017, Dr.Warbhe S Lifeline Laboratories had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹0
₹1.27 M
Charges Breakdown by Lending Institutions
- Shikshak Sahakari Bank Ltd : 0.13 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 03 Mar 2004 | Shikshak Sahakari Bank Ltd | ₹1.27 M | Satisfied |
How Many Employees Work at Dr.Warbhe S Lifeline Laboratories?
Unlock and access historical data on people associated with Dr.Warbhe S Lifeline Laboratories, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Dr.Warbhe S Lifeline Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Dr.Warbhe S Lifeline Laboratories's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
